Cell Therapy for Anal Sphincter Incontinence: Where Do We Stand?
Anal sphincter incontinence is a chronic disease, which dramatically impairs quality of life and induces high costs for the society. Surgery, considered as the best curative option, shows a disappointing success rate. Stem/progenitor cell therapy is pledging, for anal sphincter incontinence, a subst...
Main Authors: | Alexandre Balaphas, Jeremy Meyer, Raphael P. H. Meier, Emilie Liot, Nicolas C. Buchs, Bruno Roche, Christian Toso, Leo H. Bühler, Carmen Gonelle-Gispert, Frédéric Ris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/8/2086 |
Similar Items
-
Prevalence of Anal Incontinence and Constipation in Female Patients with Urinary Incontinence
by: Musa Saraçoğlu, et al.
Published: (2018-04-01) -
Differentiation of Adipose-Derived Stem Cells into Smooth Muscle Cells in an Internal Anal Sphincter-Targeting Anal Incontinence Rat Model
by: Minsung Kim, et al.
Published: (2023-02-01) -
EXPERIENCE OF APPLICATION OF VOLUME FORMING AGENT «DAM+» IN TREATMENT OF ANAL INCONTINENCE ASSOCIATED WITH INCOMPETENCE AND TRAUMA OF ANAL SPHINCTER
by: I. A. Komissarov, et al.
Published: (2016-10-01) -
The long-term prevalence of anal incontinence in women with and without obstetric anal sphincter injuries
by: Rebecca Everist, et al.
Published: (2023-03-01) -
Prevalence and Risk Factors of Anal and Fecal Incontinence in Japanese Medical Personnel
by: Kotaro Maeda, et al.
Published: (2021-10-01)